Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × pemigatinib × Clear all

Sponsor

Conditions

Acrocephalosyndactylia 5 Carcinoma, Transitional Cell 3 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Recurrence 1 Oligodendroglioma 1 Neoplasms, Unknown Primary 1 Myeloproliferative Disorders 1 Glioma 1 Glioblastoma 1 Eosinophilia 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignancies 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 10 Bevacizumab 6 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Taxes 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡